Spontaneous Conception Following High-dose Intravenous Corticosteroid Treatment for Multiple Sclerosis Exacerbation: A Case Report
Amanda Foley1, John Mackenzie2
1Midwestern University - Arizona College of Osteopathic Medicine, 2Neurosurgical Medicine, Yavapai Regional Medical Center
Background:
Multiple sclerosis (MS) is a chronic autoimmune condition that is characterized by relapsing episodes of acute demyelination within the central nervous system that can lead to neurological deficits The first-line treatment for acute MS exacerbations is intravenous (IV) glucocorticoids, most commonly methylprednisolone
Design/Methods:
We present the case of a 32-year-old woman with a history of infertility who had previously required three rounds of in vitro fertilization (IVF) to conceive. The patient presented with new-onset neurologic and ophthalmologic symptoms consistent with a MS flare. T2 weighted magnetic resonance imaging (MRI) confirmed hyperintense lesions consistent with active MS, and the patient was hospitalized for three days for treatment with IV methylprednisone.
Results:
At follow up, the patient reported natural conception following several years of infertility and prior use of in-vitro fertilization six years prior to achieve conception.
Conclusions:
Although steroid-associated fertility changes are not well characterized, this finding suggests that further research is warranted to explore the effects of exogenous glucocorticoids used in MS treatment on ovarian reserves, follicular responses, uterine receptiveness and other factors influencing female fertility.
Generative AI Usage
No, did not use generative AI in the drafting or editing in this abstract.
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.